Homburger advised Idorsia on up to CHF 250 m secured financing
Homburger advised Idorsia, as the Six-listed commercial-stage biopharmaceutical company entered into a senior secured term loan agreement of up to CHF 250 million with investment funds managed by Pharmakon Advisors.
The first tranche of CHF 150 million will be used, among other things, to refinance existing financing of the Idorsia group, with further tranches available, subject to customary conditions.
The Homburger team
The Homburger team was led by Frank Gerhard (pictured) and included Eduard De Zordi and Daniel Hulmann (all capital markets).
